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AbstrACt: Introduction: rectal cancer (rC) represents 1/3 of all diagnosed colorectal cancers. After the creation of specialized units 
to treat rC, it became fundamental to establish criteria to assess the quality of the service. Objective: to evaluate the surgical treat-
ment provided to rC patients at the Coloproctology Unit of Hospital de Braga (bH-CU) by means of quality parameters. Methods: We 
conducted an observational cross-sectional descriptive study with a convenience sample of 149 patients undergoing surgical treatment 
in this unit, from January 1st, 2007 to June 30, 2010. results: We observed that the postoperative mortality rate (4%) and the global 
dehiscence rate (14.8%) were in accordance with recommended values. sphincter sparing surgery rate (65.8%) was higher than the rec-
ommended minimum; however, more than 12 resected ganglia (36.6%) is inferior than what is recommended. the oncological results 
were analyzed by the local recurrence rate (6.7%) and the two-year survival rate (91.1%); both values are in accordance with literature. 
Conclusion: We conclude that the bH-CU surgical treatment has a quality level similar to that observed in literature.
Keywords: rectal cancer; functional coloproctology unit; quality parameters of surgical treatment.
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INtrODUCtION
Colorectal cancer (CCR) is the third most common 
cancer and ranks the fourth position as a cause of death 
by cancer worldwide1-3. Its incidence is geographical-
ly varied, and there are higher rates in North America, 
Australia and Western Europe. The lower rates are in 
developing countries4, but the incidence in these coun-
tries5 has been increasing in the past few years. 
According to the World Health Organization 
(WHO), CCR is the second most common cancer in Eu-
rope, followed by lung cancer among males and breast 
cancer among females6. Despite the high incidence, 
data from WHO from 1997 to 2007 show that mortality 
caused by CCR decreased7. The reduction in mortality 
rates was mainly due to the advances in knowledge con-
cerning the molecular mechanisms that are responsible 
for the development and progression of CCR8 and for 
the introduction of tracking programs with the popula-
tion aged more than 50 years9. In Portugal, according to 
the National Institute of Statistics, CCR is the second 
most common cancer and the main cause of death due 
to neoplastic disease10. It is more common in urban cen-
ters, such as Lisbon, Porto and Setubal11. To the north 
of Portugal, data from Registro Oncológico Regional do 
Norte (RORENO) show that CCR was the most prev-
alent cancer in 2005 for both genders, and the second 
cause of death due to cancer, after lung cancer12,13.
Rectal cancer (RC) makes up to 1/3 of the total num-
ber of diagnosed cases of CCR14. Even though the north 
of Portugal presents an incidence rate of 24.8/100,000 
inhabitants, which is higher to the incidence in Europe 
(21.2/100,000 inhabitants), the five-year survival rate 
(53%) has a much closer value to the European mean 
(53.2%)12. The therapeutic approach to RC has been 
through significant changes in the past decades, going 
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from a merely surgical treatment to a multidisciplinary 
approach15; however, despite the aforementioned ad-
vances, surgical exeresis is still essential16, since it is 
the only potentially curative treatment nowadays. There 
are currently many therapy options related to the loca-
tion of the cancer; thus, the performance of an anterior 
rectal resection (ARR) for superior rectal tumors is in-
dicated; a low anterior rectal resection with coloanal 
anastomosis is indicated for inferior rectal tumors17. As 
to the latter, since this procedure has risk of dehiscence, 
it is established that is should be complemented with 
protective ileostomy18. The abdominoperineal resection 
(APR) is currently limited; it is recommended for tumors 
that present with sphincter infiltration, for cases of fecal 
incontinence prior to tumoral symptomatology and el-
derly patients with associated comorbidity that does not 
allow an anastomosis. The same happens with the Hart-
mann’s operation (HO), which is performed when there 
are factors that contraindicate anastomosis that would 
enable the preservation of the sphincters with a safe dis-
tal margin17. Also, the local transanal resection is only 
indicated for tumors that are limited to the mucosa and 
the submucosa (T1N0M0), with no lymphovascular in-
vasion, well or moderately differentiated, with less than 
3 cm in diameter and located up to 8 cm from the anal 
margin (AM)17. One of the great advances in the past 
decades, in terms of surgical treatment for CR, was the 
introduction of the concept of total mesorectal excision 
(TME). Heald et al. showed the importance of TME in 
the two lower thirds of the rectum, with dissection un-
der direct visualization and preservation of the nervous 
plexus. The introduction of TME enabled the reduction 
of local recurrence rates for values of 6%, with a five-
year survival rate of 80%, and ten-year survival rate of 
78%15. The decrease in local recurrence rates was due 
to the fact that TME enabled the resection of RC with 
a negative circumferential margin19. This technique has 
also led to the improvement in pathological staging of 
cancer, as well as in the quality of life of the operated 
patient because of the reduction in the incidence of ves-
ical dysfunction and sexual impotence14.
The concept of margin is important to be con-
sidered in resection with a curative intent. Regarding 
RC, we should consider the distal, proximal and radial 
margins, in which the currently accepted values are 
1 cm, 5 cm and 1 mm, respectively. The involvement 
of these margins is associated with increased locore-
gional recurrence; more specifically, the involvement 
of the radial margin is associated with a recurrence risk 
of 56 – 80%, with a five-year survival rate, decreasing 
from 79 to 40%20. Another margin to be considered is 
the distal margin of the mesorectal dissection, which 
has an important prognostic value and should be 5 cm 
distal to the tumor, once it showed the presence of tu-
mor niche 2 to 3 cm below the tumor17.
As to the surgical treatment of RC, together with 
negative resection margins, a proper lymphadenecto-
my is the most important aspect21. In this context, it is 
important to perform a proper lymphadenectomy, with 
resection of at least 12 ganglia; besides reducing the 
risk of lymphatic invasion, it also prevents the sub-
staging of the tumor22.
Despite the improvements observed in the recur-
rence rate of the resectable RC, the local recurrence 
is still an issue in cases of locally advanced fixed rec-
tal cancer. The current strategy to treat such cases is 
multidisciplinary23. The primary therapy enables to in-
crease respectability, decrease the locoregional recur-
rence rate and improve the survival of the patient19,23. 
Thus, the initial treatment for locally advanced RC 
(T3-4 or N+) consists of the administration of chemo-
therapy and primary radiotherapy16,19.
The creation of units that are specialized in treat-
ing RC contributed with better results, since it improved 
the preoperative staging by using: the pelvic magnetic 
resonance and endoluminal ultrasound; the primary 
therapy after establishing the dose and proper times of 
application24 in cases of locally advanced RC; the im-
plementation of TME as a qualified technique to assess 
the obtained results22; and the establishment of stan-
dards concerning anatomopathological tecniques24. Ac-
cording to a study conducted in the United States, these 
changes are reflected in the decreased local recurrence 
rate, from 9.6 to 6.9%25. In a study group from Norway, 
the implementation of TME showed a decrease in the 
local recurrence rate, from 12% to 6%, and the survival 
rate after four years increased from 60% to 73%. The 
same happened in a randomized study conducted in the 
Netherlands, in which the local recurrence rate after 
two years was significantly lower in patients submitted 
to surgery and radiotherapy (2.4%) than in the group 
treated only with surgery (8.2%)16. Due to this evolu-
tion, many European countries, such as Germany, Swe-
den and Spain, showed the need to define new quality 
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standards, with the minimum required values, which 
are essential for the evolution of the diagnosis, staging 
and treatment of RC, for beyond the ones that are usu-
ally used, such as morbidity and mortality22,24,26.
By studying large samples, some indicators have 
been established to enable the evaluation of surgical 
quality concerning the RC treatment; these can be di-
vided into general and specific criteria, and criteria that 
study oncologic results27. General criteria are: postop-
erative mortality rate, which should be inferior to 5%, 
ideally between 2 and 3%24,27, and the global dehis-
cence rate, whose required value lies between 10 and 
15%22,24,27. Regarding the sphincter sparing surgery 
rate, it is recommended to be higher than 65%24,27, and 
the number of cases with more than 12 resected gan-
glia should be higher than 75%22; both are considered 
to be specific criteria. Finally, the criteria that study 
the oncologic results are assessed by the local recur-
rence rate, that should be lower than 10%22,24,27, and 
the ideal value for the survival rate after two years is 
between 70 and 80%24,25. Besides the aforementioned, 
these indicators enable a proper evaluation of quality 
in assistance, because it accounts for the final health 
status of the patient and its functional capacity24.
ObJECtIVE
To assess the surgical treatment given to patients 
with rectal cancer in the Coloproctology Unit of Hos-
pital de Braga, from January 1st, 2007, and June 30, 
2010, according to quality standards.
MEtHODs
Population
The study population was comprised of patients 
treated for RC from January 1st, 2007, to June 30, 2010, 
at the Coloproctology Unit of Hospital de Braga. This 
study considered as “rectal cancer” all the cases of his-
topathological diagnosis of adenocarcinoma, located 
up to 15 cm from the anal margin, measured with the 
rigid sigmoidoscopy. Inclusion criteria were: patients 
with histological diagnosis of rectal adenocarcinoma 
submitted to surgery (local resection, anterior rectal 
resection, low anterior rectal resection or abdomino-
perineal resection). Exclusion criteria were: patients 
with histological diagnosis of rectal adenocarcinoma 
that did not undergo surgery, or those in which the de-
rivative stoma was performed.
sample
A convenience sample of 149 patients diagnosed 
with RC was used, respecting the inclusion/exclusion 
criteria previously established.
Methods and data collection
Before data collection, the work was submitted to 
and approved by the Ethics Committee of Hospital de 
Braga. A prospective database of patients diagnosed 
with RC was consulted; it consisted of sociodemograph-
ic data, location of the tumor, treatment of choice, num-
ber of resected ganglia, resection margins, presence of 
postoperative morbidity and data related to the follow-up 
period as the date of local recurrence and death. 
statistical analysis
All statistical analyses were performed with the 
18.0 version of the software Package for the Social 
Sciences, (SPSS Inc. R, Chicago, Illinois, USA). A 
simple descriptive analysis of all the variables was 
conducted by defining the total number of cases and 
the absolute and relative frequencies for valid cases. 
As for the treatment of continuous quantitative vari-
ables (age, distance to anal margin and number of re-
sected ganglia) central tendency (mode and mean) and 
dispersion (standard deviation [SD]) were measured.
rEsULts
sample caracterization 
From January 1st, 2007, and June 30, 2010, 164 
patients with RC were treated at the Coloproctology 
Unit of Hospital de Braga. At first, 15 patients were not 
eligible for the study, once they were in no conditions to 
be submitted to surgery (n=7) or in case they had been 
submitted to the isolated performance of a derivative 
stoma (n=9). Thus, after the establishment of exclusion 
criteria, 149 patients were included in the study, that 
is, 91% of the patients that had been initially identi-
fied. As to gender distribution, we observed that 57% 
of the patients (n=85) were males, and 43% (n=64) 
were females. Mean age was 68±12 years; among fe-
males, it was 66±13 years, and for males it was 70±11 
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years. Mode was equal to 80 years. After observing the 
age group analysis, we noticed that most cases, 35.6%, 
occurs between the ages of 70 and 80 years (n=53) 
(Figure 1). The most common location of RC was the 
medium rectum, in 53% of the cases, followed by the 
lower and upper rectum, in 27.5 and 19.5% of the cases, 
respectively (Table 1). The mean distance to the anal 
margin was 8.5±4.3 cm. After staging, 27.5% (n=41) 
of the patients underwent primary therapy followed by 
surgery; out of these, chemoradiotherapy was used in 
25.5% of the patients (Table 2). 
Evaluation of surgery quality parameters 
Type of surgery
Concerning the performed surgeries, 98.7% 
(n=147) were elective, and 93.3% (n=139) of the cas-
es, it had a curative intent. The most common surgery 
was the low anterior rectal resection, 30.2% (n=45), 
followed by the abdominoperineal resection (22.1%) 
(n=33). As demonstrated in Table 3, 65.8% of the sur-
geries were classified as “Sphincter Sparing Surgery”.
Anastomotic dehiscence
Out of the 149 studied cases, 22 presented with 
postoperative morbidity classified as “anastomotic de-
hiscence”. In this group, 9 patients needed surgical re-
intervention. After crossing the variables “type of sur-
gery” and “anastomotic dehiscence”, it was possible 
to show that the low anterior rectal resection is the sur-
gical procedure that presents the highest global anas-
tomotic dehiscence rate, with 6.8% of the cases; out of 
these, 3.4% were conservatively treated, and the other 
3.4% needed surgical reintervention (Table 4). After 
analyzing the global dehiscence rate along the years 
of the study, we observed that 2007 and 2009 present-
ed the highest percentage, with 4.7% of the cases; in 
2010, this value decreased (Figure 2). Out of the 22 
patients who presented with anastomotic dehiscence, 
only 1 (0.7%) was submitted to primary radiotherapy.
Postoperative mortality
The postoperative mortality rate was 4.0% (n=6). 
From these patients, 3 presented with postoperative 
morbidity characterized as anastomotic dehiscence; 
two were submitted to conservative treatment, and 
one underwent surgery.
Figure 1. Distribution of the “Age” variable by age groups.
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Absolute N° (n) Frequency (%)
Superior rectum 29 19.5
Medium rectum 79 53.0
Inferior rectum 41 27.5 
Total 149 100.0
Table 1. Characterizing the variable “Anatomical 
Location”.
Primary treatment
Absolute N° (n) Frequency (%)
No primary 
treatment 108 72.5
CT + RT 38 25.5
CT 1 0.7
RT 2 1.3
Total 149 100
Table 2. Characterizing the variable “Primary 
Treatment”. 
CT: chemotherapy; RT: radiotherapy.
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Number of analyzed ganglia
The mean of analyzed ganglia (gg) was 11±7 gan-
glia, the median was 9.5 and the mode was 6 ganglia.
The analysis of 12 or more ganglia was only 
observed in 36.6% of the cases (n=49); in the other 
63.4% (n=85), an inferior number of ganglia were 
analyzed. Out of the 41 cases submitted to primary 
therapy, 70.7% (n=29) presented a number of ana-
lyzed ganglia inferior to 12. From the 85 cases with 
less than 12 analyzed ganglia, 29 cases (34.1%) had 
primary therapy.
Locoregional recurrence
The global recurrence rate was 6.7% (n=10). The 
patients submitted to primary therapy presented an in-
ferior recurrence rate, 1.3%, in relation to those who 
underwent isolated surgery (5.4%).
Survival after 2 years
The survival rate after 2 years was 91.9% in the 
studied sample.
Figure 2. Evolution of the variable “Anastomotic dehiscence”.
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type of surgery Absolute N° (n) Frequency (%) sphincter sparing surgery
Low anterior rectal resection 45 30.2 65.8 %
Anterior rectal resection 28 18.8
Low anterior rectal resection + ileostomy 21 14.1
Local Resection 4 2.7
Hartmann’s operation 18 12.1 34.2 %
Abdominoperineal resection 33 22.1
Total 149 100.0
CT: chemotherapy; RT: radiotherapy
Table 3. Characterizing the variable “Type of surgery”.
Absolute N°(n) Frequency (%)
Dehiscence – Conservative treatment 13 8.8
Low anterior rectal resection 5 3.4
Abdominoperineal resection 5 3.4
Low anterior rectal resection  + ileostomy 3 2
Dehiscence – surgical treatment 9 6.0
Low anterior rectal resection 5 3.4
Abdominoperineal resection 4 2.6
Low anterior rectal resection  + ileostomy 0 0
Total 22 14.8
Table 4. Crossing variables “Type of surgery” and “Anastomotic dehiscence”.
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DIsCUssION
The treatment of RC has progressed for the past 
few decades15, and this progress is mostly due to the 
creation of functional units that are specifically directed 
to this pathology24. Many European countries, such as 
Norway, the Netherlands, Germany, Sweden, France, 
Denmark and Spain, have been working to define new 
quality standards to establish minimum required values 
for the surgical treatment of RC22,24,26,28-32. 
The requirement for the creation of coloproctolo-
gy functional units is based on many studies that dem-
onstrate that the treatment of patients with specific di-
agnoses, such as RC, is better in hospitals that receive 
a lot of cases of this pathology; and although it might 
sound true, this may be more related to specific char-
acteristics of the surgeon than to the number of cases 
in the hospital33,34. In Europe, it is acknowledged that 
the surgeon factor, especially the technique, the ability 
and the practice, are essential and influence the results 
of the treatment for RC35. Thus, the sub specializa-
tion of colorectal surgeons who are especially trained 
and have performed a high number of surgeries, is one 
of the most important predictors of quality concern-
ing colorectal surgery33,34. In 2006, Rogers et al. sug-
gested at least 13 rectal resections per surgeon as the 
minimum value required for maintaining the certifi-
cate in colorectal surgery for a period of 4 years, and 
in hospitals that have at least 84 surgeries of this type 
during this period34. In Sweden, as in this study, Mar-
tling et al. observed that the high number of surger-
ies is associated with better results, and defined that a 
group reaches such classification when each surgeon 
performs at least 12 rectal resections in a year36.
 In Portugal, there are many coloproctology 
functional units; however, there are few studies that 
evaluate quality standards. So, this study aims to au-
dit the quality of the health care service that is present 
at the functional units of Hospital de Braga in order to 
provide a work base that allows its improvement.
After analyzing the data concerning the function-
al units of Hospital de Braga, from January 1st, 2007, 
to June 30, 2010, 164 patients with RC were treated, 
and since the unit had three surgeons, these values 
are clearly above the suggested by the two aforemen-
tioned studies34,36 for the performance of RC surgery, 
so to offer quality standards to these patients. 
Concerning the treated patients, it was observed 
that males are more affected, in 57% of the cases, and that 
92.4% of the cases are comprised in age groups older 
than 50 years, which is in accordance with literature1,3,37. 
As to the location of the RC, our studied showed that 
53% of the cases were in the medium rectum, which is 
similar to findings from studies conducted in Germany, 
Spain and the United States of America, in which 40 to 
55% of the cancers had this anatomical location22,25,38.
The administration of primary therapy is current-
ly essential to approach locally advanced RC or with 
ganglion invasion, since it increases the possibility of 
resection, decreases the locoregional recurrence rate 
and increases survival rates23. In this study, after stag-
ing, 27.5% (n=41) of the patients underwent primary 
therapy followed by surgery.
Concerning the performed surgeries, 93.3% 
(n=139) of the cases had curative intent, which is 
higher than the values found in literature, that shows 
values such as 91.5% in Norway28, 83% in Sweden39 
and 64% in the Netherlands40. This result can be due 
to the fact that we are located in a region with high 
incidence of colorectal cancer; this is why patients 
have been tracked for the past few years, which en-
abled the early diagnosis, as well as the relation be-
tween the functional unit and the health centers; this 
way, patients were rapidly referred. 
The most common surgery in the coloproctology 
functional unit was the low anterior rectal resection 
(30.2%), which is in accordance with rates found in 
literature, of 39.5%38 and 47.3%23. 
As to the parameter “sphincter sparing surgery”, 
in Sweden and Spain the recommended values are 
higher than 70%24,39 of the performed surgery; in Nor-
way and the Netherlands, the ideal value is between 
65 and 70%28,40. The result was 65.8%, which is close 
to the minimum value required in these studies. This 
value can be explained because the ultralow anterior 
rectal resection is not performed with coloanal anas-
tomosis, and also because of the high percentage of 
cases in comparison to other series of performed Hart-
mann’s operation, 12.1% (n=18). Out of these patients, 
only one was submitted to urgent surgery; the others 
underwent elective surgery, in which the “sphincter 
sparing” resection could be performed, but due to the 
old age of the patients (mode of 80 years), with co-
morbidities associated with sphincter malfunctions, it 
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was chosen to perform a definitive stoma in order to 
avoid the high risk of fecal incontinence.
The rate of abominoperineal resections per-
formed was 22.1% (n=33), which is within the limits 
described in literature, from 22 and 27%41, strongly 
influenced by the number of patients in the center. For 
tumors that are under the 8 cm from the anal margin, 
the described values range from 44.6 to 44.8%41.
This rate has been considered as one of the re-
liability criteria of the functional units41-43; however, 
such criteria are being discussed41,42, since they de-
pend on the percentage of RC located in the inferior 
1/3 of the rectum that each unit presents; in this study, 
it was 27.5% of the cases.
Concerning the postoperative morbidity analysis, 
we chose to only characterize the anastomotic dehiscence 
since it is the main cause of morbimortality of rectal re-
section35. Values of 15%24 are described in Spanish stud-
ies, but other countries presented inferior numbers: 9% in 
Sweden39, 10% in Germany, 10% in Norway28, and 12% 
in the Netherlands40. The first issue we face to compare 
values concerning the coloproctology functional units at 
Hospital de Braga with data presented in literature is the 
definition of this concept. Except for the German study, 
none of the others define “anastomotic dehiscence”. This 
problem is registered in literature, since there are many 
studies related to dehiscence values; a review conduct-
ed by Bruce et al. on the incidence of anastomotic de-
hiscence post colorectal surgery analyzed 97 studies, in 
which 57 different definitions of anastomotic dehiscence 
were defined by the need of surgical reintervention, clini-
cal findings or radiological criteria, thus making the com-
parison between studies more difficult44.
In this study, the anastomotic dehiscence was 
defined as colorectal anastomotic failure, diagnosed 
by clinical or radiological criteria, with or without 
the need for the surgical treatment, which represents 
a total dehiscence rate of 14.8% (n=22); this value 
would decrease to 6% (n=9) in case only the patients 
who needed surgical reintervention were considered. 
When we analyze which “Type of surgery” presents 
the higher total dehiscence rate, we observe that the 
low anterior rectal resection is the highest, in 6.8% 
of the cases, which is in accordance with literature, 
since the risk of dehiscence depends on the level of 
anastomosis, among other factors, that is, bigger in the 
medium and inferior rectum45. 
Another important aspect in the data analysis is 
that the low anterior rectal resection with ileostomy 
presents the lowest total dehiscence value, 2%, and 
also that all the other cases (n=3) were treated without 
the new surgical intervention.
Even though the primary therapy increases the 
risk of dehiscence, this study did not have enough data 
to establish such a relation45.
Data obtained after the analysis of the evolution 
of the variable “anastomotic dehiscence” throughout 
the studied years are inconclusive. Annual values are 
very similar, however, a gradual increase in dehis-
cence cases that needed surgical reintervention was 
observed. This can be a result of lower anastomoses 
that are performed with the years, due to the accumu-
lated experience, thus causing a higher risk of dehis-
cence. The lowest dehiscence value was observed in 
2010, concerning the first six months of the year; al-
though, there is a tendency to reduce such number.
As to the postoperative mortality rate, accord-
ing to countries like Sweden, Norway, the Nether-
lands and Spain, it should be around 2 and 3%24,28,39,40; 
however, this interval is not a consensus, and in Ger-
many the recommendation is that it should be inferior 
to 5%22. In our study, the postoperative mortality rate 
was 4.0% (n=6) and, as described in literature, this 
rate is directly related to the anastomotic dehiscence 
rate, once it is the main cause of death at the post-
operative for the colorectal patient24. Out of these six 
patients, three had anastomotic dehiscence, and one 
underwent a new surgery. Besides, other aspects are 
also important, especially the old age of most patients 
in the sample, which leads to low resistance to the in-
tercurrences that occur during admission, as well as 
associated comorbidities25; thus, it was the cause of 
death for other 3 patients (respiratory failure, myocar-
dial infarction and pulmonary edema).
The evaluation of the ganglia involvement is es-
sential for the staging of the RC, and significant cor-
relations have been established between the number of 
analyzed ganglia and the survival of patients46. In or-
der to study the number of analyzed ganglia, the cohort 
value was established based on criteria of different sur-
geon associations, which recommend the analysis of at 
least 12 negative ganglia41,46,47. This way, it is possible 
to confirm with 90% accuracy that the patient is free of 
lymphatic invasion38,48. In one of the studies conduct-
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ed in Germany, it was defined that more than 75% of 
the surgeries should have more than 12 analyzed gan-
glia; in Spain, the value presented for such indicator is 
around 71%22,38. In this context, the percentage of cases 
in which 12 or more ganglia were analyzed (36.6%) is 
lower than the minimum required value. Three types of 
factors can contribute with this value: the ones that de-
pend on anatomy and on the biological conditions of the 
patient; the ones that depend on surgical technique; and 
the ones that depend anatomopathological technique48.
Concerning the factors that depend on the pa-
tient, the anatomical factors stand out, with individual 
variations related to the number of lymphatic ganglia, 
the age of the patient, with the tendency to perform 
surgeries that are less aggressive in oncological terms, 
with the old age of the patients48 and the administra-
tion of the primary treatment, which causes the ganglia 
to decrease in size, thus making resection harder46. 
Concerning this last aspect in the analyzed study, 
70% of the cases that were submitted to primary ther-
apy presented a number of analyzed ganglia inferior 
to 12; however, they represent only 34.1% of the cases 
with less than 12 analyzed ganglia, thus, the low per-
centage cannot be only related to that fact.
As to the surgical technique, the analysis of resec-
tion margins that led to the observation that out of the 
164 operated patients, only one presented with radial 
margin invasion; with this, we concluded that a proper 
total mesorectal excision was performed, and that the 
lymphatic ganglia that were present in the mesorec-
tum were completely removed; they might or might not 
have been accounted for. In literature, abominoperineal 
resection is described as the surgery with the lowest 
number of ganglia48. Since this surgery ranks in second 
place in our series as to the most performed surgeries, 
this might have contributed with the obtained results.
Finally, these results can be justified by the anato-
mopathological technique, since this unit is still based 
on the classical model of visual identification and gan-
glion palpation, which is a slow and delicate process, 
and also, in 70% of the cases, ganglia have less than 
5 mm in diameter and could easily go unnoticed dur-
ing the resection process48.
The locoregional recurrence of RC is one of the 
most feared situations, since it is usually inoperable 
and the patient could die slowly and painfully43. As 55 
to 80% of the recurrence cases happen in the first two 
years after surgery49, the local recurrence rate in this 
period is one of the main indicators of the oncological 
results. The maximum value established for that rate is 
10%, and it is presented by the Spanish series24; how-
ever, in decreasing order, we found the following val-
ues: 9% in the Netherlands40, 6% in Sweden28,39, and 
4% in Norway28. In these three countries, this limit is 
lower for patients submitted to the primary treatment, 
and the minimum required value is between 1.5% and 
2.4%28,39,40. In this area, the studied unit presents good 
numbers, with a local recurrence rate of 6.8%, subdi-
vided into 6.1% of recurrence without primary treat-
ment and 0.7% with primary treatment.
CONCLUsION
The periodic evaluation of quality standards con-
cerning the surgery of RC is important in any coloproc-
tology functional unit, since it enables internal monitor-
ing, identifies the key points as to how to intervene for 
better results, and yet, at the same time, it enables to 
inform the patients in the unit about the expected results 
at the institution, instead of those in literature.
In this study, quality standards were classified as: 
general, specific and those that study oncological results. 
Concerning general criteria, the postoperative mortal-
ity rate, 4%, and the global dehiscence rate, 14.8%, are 
within the values recommended in literature. In the cat-
egory of specific criteria, the rate of sphincter sparing 
surgeries, 65.8%, was higher than the recommended 
limit; however, the rate concerning more than 12 resect-
ed ganglia, 36.6%, is lower than recommended. Finally, 
the analysis of oncological results was conducted by a 
local recurrence rate, 6.7%, and survival rate after two 
years, 91.1%, both within recommended values.
With this study, we can observe that the values in 
this unit are within the values recommended in literature 
for most of the quality criteria. The exception, and one 
of the items that should receive short term investments, 
is the improvement of the anatomopathological charac-
terization of the number of assessed ganglia. However, 
it is important to emphasize that with the rapid thera-
peutic advances, it is necessary to discuss and regularly 
rethink the minimum required values, as well as to de-
fine a limit of standards that are easy to calculate, so 
that the evaluation of the results by each of the surgeons 
in the unit can be a simple and periodic process.
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rEsUMO: Introdução: O câncer do reto (Cr) constitui cerca de 1/3 da totalidade dos casos de câncer colorretal diagnosticados. 
Após a criação de unidades especializadas no tratamento do Cr, tornou-se fundamental estabelecer critérios que permitam avaliar a 
qualidade do tratamento prestado. Objetivo: Avaliar, segundo parâmetros de qualidade, o tratamento cirúrgico prestado aos doentes 
com Cr, na Unidade Funcional de Coloproctologia (UFC) do Hospital de braga (Hb). Métodos: realizou-se um estudo observacional, 
transversal e descritivo com uma amostra de conveniência constituída por 149 doentes operados de Cr entre 1º de Janeiro de 2007 e 
30 de Junho de 2010. resultados: Observou-se que a taxa de mortalidade pós-operatória (4%) e a taxa global de deiscência (14,8%) 
se encontram dentro dos valores recomendados. A taxa de realização de cirurgia poupadora de esfíncteres (65,8%) foi superior ao 
limite mínimo aconselhado; no entanto, a taxa de número de gânglios ressecados superior a 12 (36,6%), encontra-se aquém do exigível. 
Os resultados oncológicos foram analisados através da taxa de recidiva local, 6,7%, e da taxa de sobrevida aos 2 anos, 91,1%, ambos 
dentro dos valores propostos na literatura. Conclusão: Concluímos que o tratamento cirúrgico prestado na UFC do Hb apresenta um 
nível de qualidade semelhante ao globalmente recomendado.
Palavras-chave: câncer do reto; unidade funcional coloproctologia; parâmetros de qualidade do tratamento cirúrgico. 
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